Exelixis Inc EXEL.OQ EXEL.O is expected to show a rise in quarterly revenue when it reports results on November 4 for the period ending September 30 2025
The Alameda California-based company is expected to report a 9.3% increase in revenue to $589.77 million from $539.54 million a year ago, according to the mean estimate from 18 analysts, based on LSEG data. (Sales majority is on Total revenue basis)
LSEG's mean analyst estimate for Exelixis Inc is for earnings of 61 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 8 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Exelixis Inc is $45.00, about 13.5% above its last closing price of $38.94
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | 0.58 | 0.56 | 0.65 | Beat | 16.3 |
Mar. 31 2025 | 0.37 | 0.36 | 0.55 | Beat | 52 |
Dec. 31 2024 | 0.44 | 0.43 | 0.48 | Beat | 12.9 |
Sep. 30 2024 | 0.35 | 0.35 | 0.40 | Beat | 15.6 |
Jun. 30 2024 | 0.31 | 0.30 | 0.77 | Beat | 154 |
Mar. 31 2024 | 0.23 | 0.24 | 0.20 | Missed | -16.1 |
Dec. 31 2023 | 0.22 | 0.21 | 0.27 | Beat | 27.1 |
Sep. 30 2023 | 0.10 | 0.10 | 0.00 | Missed | -100 |
This summary was machine generated October 31 at 21:55 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)